Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Chemoprevention Trial Of Selenium Supplementation In Persons With Resected Stage I Non-Small Cell Lung Cancer

NCT00008385 is registered in ClinicalTrials.gov with ECOG-ACRIN Cancer Research Group as lead sponsor.

NCT NCT00008385
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00008385 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Chemoprevention Trial Of Selenium Supplementation In Persons With Resected Stage I Non-Small Cell Lung Cancer
Lead sponsor
ECOG-ACRIN Cancer Research Group
Phase
Phase 3
Overall status
Completed
Start date
December 18, 2000
Completion date
November 30, 2019
Enrollment
1,772 (actual)
Sites
532

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer